Abstract
Chagas disease and leishmaniasis are important parasitic diseases afflicting the poorest countries in the world. The number and efficacy of drugs available for the treatment of human trypanosomiasis and leishmaniasis is limited and are not ideal, as they are often associated with severe side effects. The emerging resistance to the available drugs against these diseases represents an additional problem. However, some headway has been made in identifying factors that are keys to parasite virulence and the pathogenesis of the diseases they produce. Parasite-derived proteases have been widely studied in connection to parasite virulence and disease pathogenesis. Studies focused on plant-derived compounds active against species of Trypanosoma and Leishmania have reveled promising results, which highlights natural products as a valuable source of drug candidates. This review focuses on phytochemicals able to target specific Trypanosoma spp. and Leishmania spp. enzymes showing a modern approach to the development of new drugs against trypanosomiasis and leishmaniasis.
Keywords: Phytochemicals, Trypanosoma, Leishmania, enzymes, Chagas disease, DNA topoisomerases, Terpinoids, Flavonoids, Steroids, Betulinic acid
Current Enzyme Inhibition
Title: Trypanosomatid Enzymes as Targets for Plant-Derived Compounds: New Perspectives for Phytotherapeutic Approaches
Volume: 7 Issue: 1
Author(s): Igor de Almeida Rodrigues, Ana Claudia Fernandes Amaral and Maria do Socorro dos Santos Rosa
Affiliation:
Keywords: Phytochemicals, Trypanosoma, Leishmania, enzymes, Chagas disease, DNA topoisomerases, Terpinoids, Flavonoids, Steroids, Betulinic acid
Abstract: Chagas disease and leishmaniasis are important parasitic diseases afflicting the poorest countries in the world. The number and efficacy of drugs available for the treatment of human trypanosomiasis and leishmaniasis is limited and are not ideal, as they are often associated with severe side effects. The emerging resistance to the available drugs against these diseases represents an additional problem. However, some headway has been made in identifying factors that are keys to parasite virulence and the pathogenesis of the diseases they produce. Parasite-derived proteases have been widely studied in connection to parasite virulence and disease pathogenesis. Studies focused on plant-derived compounds active against species of Trypanosoma and Leishmania have reveled promising results, which highlights natural products as a valuable source of drug candidates. This review focuses on phytochemicals able to target specific Trypanosoma spp. and Leishmania spp. enzymes showing a modern approach to the development of new drugs against trypanosomiasis and leishmaniasis.
Export Options
About this article
Cite this article as:
de Almeida Rodrigues Igor, Claudia Fernandes Amaral Ana and do Socorro dos Santos Rosa Maria, Trypanosomatid Enzymes as Targets for Plant-Derived Compounds: New Perspectives for Phytotherapeutic Approaches, Current Enzyme Inhibition 2011; 7 (1) . https://dx.doi.org/10.2174/157340811795713792
DOI https://dx.doi.org/10.2174/157340811795713792 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of 2-Antiplasmin in Cardiovascular System
Letters in Drug Design & Discovery Recent Patents on Ophthalmic Nanoformulations and Therapeutic Implications
Recent Patents on Drug Delivery & Formulation Severe Neutropenia in a Renal Transplant Patient Suggesting an Interaction Between Mycophenolate and Fenofibrate
Current Drug Safety Impact of Hyperhomocyst(e)inemia on Endothelial Function
Vascular Disease Prevention (Discontinued) Percutaneous Treatment of Hydatid Liver Cyst
Recent Patents on Anti-Infective Drug Discovery Role of Sympathetic Nerve Activity in Obesity, Hypertension and Metabolic Syndrome
Current Hypertension Reviews Ultrasonic-Promoted One-Pot Synthesis of 4H-chromenes, pyrano[2,3- d]pyrimidines, and 4H-pyrano[2,3-c]pyrazoles
Letters in Organic Chemistry Role of the Autonomic Nervous System and Neuropeptides in the Development of Obesity in Humans: Targets for Therapy?
Current Pharmaceutical Design The Role of Colchicine in the Prevention of Cerebrovascular Ischemia
Current Pharmaceutical Design Cardiac MRI in Autoimmune Diseases: Where Are We Now?
Current Cardiology Reviews Cardiac Metabolism in Myocardial Ischemia
Current Pharmaceutical Design Targeting Cardiomyocyte Ca<sup>2+</sup> Homeostasis in Heart Failure
Current Pharmaceutical Design Angiotensin II Roles in Human Vascular Tone Control
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Progress Towards Discovery of Antifibrotic Drugs Targeting Synthesis of Type I Collagen
Current Medicinal Chemistry Myopericarditis, as the First Sign of Rheumatoid Arthritis Relapse, Evaluated by Cardiac Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Editorial: MicroRNA-33 Inhibition: A Potential Adjunct to Statin Therapy?
Current Vascular Pharmacology The Role of Melanocortin Peptides and Receptors in Regulation of Energy Balance
Current Pharmaceutical Design Clinical Pharmacotherapy and Drug Development for Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Oxidative Stress in the Pathogenesis/Treatment of Atherosclerosis
Current Nutrition & Food Science